Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07700004

The King's Brief Lnterstitial Lung Disease Questionnaire

The aim of this study is to examine the validity and reliability of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals with Interstitial Lung Involvement Secondary to Rheumatological Diseases.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Having been diagnosed with interstitial lung disease by a rheumatologist,

  • Being 18 years of age or older,
  • Agreeing to participate in the study.

Exclusion criteria

- Presence of a neurological disease

  • Presence of any orthopedic problem that affects functionality
  • History of any orthopedic surgery in the last year
  • Inability to speak or understand Turkish fluently
  • Presence of a psychiatric illness that affects cooperation
  • Heart failure that affects daily living activities
  • Being a cancer patient

Treatment and study plan

patient reported outcome measures

Behavioral

King's Brief lnterstitial Lung Disease Questionnaire, Arthritis Impact Measurement Scales (AIMS2)-Short Form, Modified Medical Research Council (mMRC) Dyspnea Scale, Visual Analog Scale were evaluated.

Primary outcomes

  1. King's Brief lnterstitial Lung Disease Questionnaire

    Time frame: 10 minutes

    It consists of 15 items and has a seven-point Likert scale.

Secondary outcomes

  1. Arthritis Impact Measurement Scales (AIMS2)-Short Form

    Time frame: 15 minutes

    AIMS2-SF is a 26-item shortened form of AIMS2 and covers five components of quality of life.

  2. Modified Medical Research Council (mMRC) Dyspnea Scale

    Time frame: 5 minutes

    This scale provides information about perceived levels of shortness of breath, consisting of five stages.

  3. Visual Analog Scale

    Time frame: 3 minutes

    In our study, "respiratory distress" will be assessed using the Visual Analog Scale. 0 will be defined as "I never experience respiratory distress," and 10 as "I do not always experience respiratory distress."

Study contacts

Contact information is provided by the study sponsor or research team.

Elif Gur Kabul

CONTACT

[email protected]

+902762212144

Sponsors and collaborators

Lead sponsor

Pamukkale University

Other

Registry information

Official study title

Investigation of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals With Interstitial Lung Involvement Secondary to Rheumatological Diseases

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 13, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.